Analysis of MIR27A (rs11671784) Variant Association with Systemic Lupus Erythematous
暂无分享,去创建一个
M. Fawzy | E. Toraih | S. Qusti | E. M. Alshammari | M. Hussein | S. Kattan | Z. Khired | A. K. Alzahrani | Ahmad J. Milebary
[1] M. González-Gay,et al. Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients , 2022, Biomolecules.
[2] M. Guma,et al. Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes , 2022, Frontiers in Immunology.
[3] Huali Zhang,et al. EZH2: Its regulation and roles in immune disturbance of SLE , 2022, Frontiers in Pharmacology.
[4] J. D. Di Noia,et al. AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination , 2022, Science advances.
[5] A. Nongnuch,et al. Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios , 2022, PloS one.
[6] M. Fawzy,et al. MicroRNA-499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes-associated end-stage renal disease , 2021, Experimental and therapeutic medicine.
[7] M. Assarehzadegan,et al. MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis , 2021, Scientific Reports.
[8] M. Fawzy,et al. Association of microRNA-34a rs2666433 (A/G) Variant with Systemic Lupus Erythematosus in Female Patients: A Case-Control Study , 2021, Journal of clinical medicine.
[9] Peizeng Yang,et al. Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease , 2021, Disease markers.
[10] S. Mohammadi,et al. Genetic variation in CYP1A1 and AHRR genes increase the risk of systemic lupus erythematosus and exacerbate disease severity in smoker patients , 2021, Journal of biochemical and molecular toxicology.
[11] Y. Errami,et al. MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis , 2021, Cancers.
[12] Lifeng Chen,et al. Upregulating miR-27a-3p inhibits cell proliferation and inflammation of rheumatoid arthritis synovial fibroblasts through targeting toll-like receptor 5 , 2021, Experimental and therapeutic medicine.
[13] Ying Zhao,et al. ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells , 2021, Frontiers in Immunology.
[14] D. Ribatti,et al. SMADS-Mediate Molecular Mechanisms in Sjögren’s Syndrome , 2021, International journal of molecular sciences.
[15] Sangdun Choi,et al. Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook , 2021, International journal of molecular sciences.
[16] E. Andrés-León,et al. The Implications of ncRNAs in the Development of Human Diseases , 2021, Non-coding RNA.
[17] R. Zhao,et al. Increased Expression of PPAR-γ Modulates Monocytes Into a M2-Like Phenotype in SLE Patients: An Implicative Protective Mechanism and Potential Therapeutic Strategy of Systemic Lupus Erythematosus , 2021, Frontiers in Immunology.
[18] Wei Wei,et al. Immuno-Hippo: Research Progress of the Hippo Pathway in Autoimmune Disease. , 2020, Immunology letters.
[19] Ziye Wang,et al. IFN-γ Mediates the Development of Systemic Lupus Erythematosus , 2020, BioMed research international.
[20] Afaf T. Ibrahiem,et al. Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study , 2020, Scientific Reports.
[21] M. Fawzy,et al. Association of microRNA 17 host gene variant (rs4284505) with susceptibility and severity of systemic lupus erythematosus , 2020, Immunity, inflammation and disease.
[22] Sudong Liu,et al. Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus , 2020, Clinics.
[23] Q. Lu,et al. The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review , 2020, Journal of Autoimmunity.
[24] Jingyan Dong,et al. Association of two polymorphisms of miRNA-146a rs2910164 (G > C) and miRNA-499 rs3746444 (T > C) with asthma: a meta-analysis , 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.
[25] G. C,et al. Investigating the role of microRNA-27a gene polymorphisms and its interactive effect with risk factors in gastrointestinal cancers , 2020, Heliyon.
[26] Qing Zhou,et al. New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond , 2020, Journal of clinical medicine.
[27] K. Kavousi,et al. An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus , 2020, Arthritis Research & Therapy.
[28] C. E. Condrat,et al. miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis , 2020, Cells.
[29] Xiaoqiong Gu,et al. Association between the miRNA‐149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population , 2019, Journal of clinical laboratory analysis.
[30] M. Infantino,et al. European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist’s point of view , 2019, Annals of the Rheumatic Diseases.
[31] A. T. R. de Vasconcelos,et al. miRNA Genetic Variants Alter Their Secondary Structure and Expression in Patients With RASopathies Syndromes , 2019, Front. Genet..
[32] D. Gladman,et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus , 2019, Arthritis & rheumatology.
[33] Se Jin Park,et al. Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-analysis , 2019, Disease markers.
[34] T. Aune,et al. Juvenile idiopathic arthritis associated with a mutation in GATA3 , 2019, Arthritis Research & Therapy.
[35] G. Novelli,et al. The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A , 2019, International journal of molecular sciences.
[36] S. Ooka,et al. Anti-IL-10 antibody in systemic lupus erythematosus , 2019, Open access rheumatology : research and reviews.
[37] M. Fawzy,et al. Deregulated MicroRNA Signature Following Glioblastoma Irradiation , 2019, Cancer control : journal of the Moffitt Cancer Center.
[38] A. Dejean,et al. The role of Eomes in human CD4 T cell differentiation: A question of context , 2018, European journal of immunology.
[39] K. Saliminejad,et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods , 2018, Journal of cellular physiology.
[40] Tianfu Wu,et al. Insulin-Like Growth Factor Binding Proteins in Autoimmune Diseases , 2018, Front. Endocrinol..
[41] C. Peng,et al. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..
[42] M. Barbouche,et al. Impaired TGF‐&bgr; signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL‐22 , 2018, Cytokine.
[43] K. Gillespie,et al. Unravelling the Roles of Susceptibility Loci for Autoimmune Diseases in the Post-GWAS Era , 2018, Genes.
[44] S. Tenzer,et al. Targeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity , 2018, The EMBO journal.
[45] Xiao Li,et al. B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Erythematosus , 2018, Front. Immunol..
[46] Y. Tao,et al. Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer , 2018, Molecular Cancer.
[47] J. Nossent,et al. Insulin-like growth factor-1 (IGF1) in systemic lupus erythematosus: relation to disease activity, organ damage and immunological findings , 2018, Lupus.
[48] M. Østergaard,et al. Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial , 2018, The Journal of Rheumatology.
[49] M. Fawzy,et al. MicroRNA–target cross-talks: Key players in glioblastoma multiforme , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[50] Afaf T. Ibrahiem,et al. MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma , 2017, Oxidative medicine and cellular longevity.
[51] M. Fawzy,et al. Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma , 2017, Respiratory Research.
[52] N. Shen,et al. Novel insights of microRNAs in the development of systemic lupus erythematosus , 2017, Current opinion in rheumatology.
[53] Q. Lu,et al. Translating epigenetics into clinic: focus on lupus , 2017, Clinical Epigenetics.
[54] O. Peralta-Zaragoza,et al. Functional polymorphisms in pre-miR146a and pre-miR499 are associated with systemic lupus erythematosus but not with rheumatoid arthritis or Graves’ disease in Mexican patients , 2017, Oncotarget.
[55] I. Prinz,et al. Eomes expression reports the progressive differentiation of IFN‐γ‐producing Th1‐like γδ T cells , 2017, European journal of immunology.
[56] S. Salah,et al. Unraveling the expression of microRNA‐27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients , 2017, International journal of rheumatic diseases.
[57] X. Ke,et al. A functional variant of miRNA‐149 confers risk for allergic rhinitis and comorbid asthma in Chinese children , 2017, International journal of immunogenetics.
[58] G. Cheng,et al. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus , 2017, Arthritis Research & Therapy.
[59] Ji-min Zhu,et al. Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population , 2017, Rheumatology International.
[60] L. Rönnblom,et al. Systemic lupus erythematosus: still a challenge for physicians , 2017, Journal of internal medicine.
[61] H. Lorenzi,et al. High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus , 2016, PloS one.
[62] C. Cogoni,et al. MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions , 2016, International journal of molecular sciences.
[63] M. Fawzy,et al. MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors , 2016, Molecular Diagnosis & Therapy.
[64] J. Ji,et al. Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis , 2016, Autoimmunity.
[65] M. Fawzy,et al. Association of MicroRNA-196a2 Variant with Response to Short-Acting β2-Agonist in COPD: An Egyptian Pilot Study , 2016, PloS one.
[66] M. Fawzy,et al. Precursor miR-499a Variant but not miR-196a2 is Associated with Rheumatoid Arthritis Susceptibility in an Egyptian Population , 2016, Molecular Diagnosis & Therapy.
[67] Jingpu Shi,et al. Comprehensive review of genetic association studies and meta-analysis on miRNA polymorphisms and rheumatoid arthritis and systemic lupus erythematosus susceptibility. , 2016, Human immunology.
[68] J. Del Favero,et al. Genetic variants in microRNA genes: impact on microRNA expression, function, and disease , 2015, Front. Genet..
[69] Artemis G. Hatzigeorgiou,et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..
[70] Honglin Hu,et al. rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression. , 2015, Biochemical and biophysical research communications.
[71] V. Baekelandt,et al. Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis , 2015, Brain, Behavior, and Immunity.
[72] Chun-Shu Wong. The Role of Adenomatous Polyposis Coli in T cell biology: Development, Naïve T cell maintenance, and T cell Homeostatic Proliferation. , 2015 .
[73] Ge Yan,et al. rs11671784 G/A and rs895819 A/G Polymorphisms Inversely Affect Gastric Cancer Susceptibility and miR-27a Expression in a Chinese Population , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[74] Chang Liu,et al. An Exploration of Evolution, Maturation, Expression and Function Relationships in Mir-23∼27∼24 Cluster , 2014, PloS one.
[75] Yiguo Jiang,et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility , 2014, Oncogene.
[76] Yong Zhu,et al. A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis , 2013, Nucleic acids research.
[77] Li He,et al. MicroRNA-499 rs3746444 Polymorphism and Autoimmune Diseases Risk: A Meta-Analysis , 2014, Molecular Diagnosis & Therapy.
[78] A. El-Shal,et al. Association of microRNAs genes polymorphisms with rheumatoid arthritis in Egyptian female patients. , 2013, Joint, bone, spine : revue du rhumatisme.
[79] K. Nakayama,et al. F-box and WD Repeat Domain-containing-7 (Fbxw7) Protein Targets Endoplasmic Reticulum-anchored Osteogenic and Chondrogenic Transcriptional Factors for Degradation* , 2013, The Journal of Biological Chemistry.
[80] Lin Wang,et al. Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis , 2013, PloS one.
[81] A. La Cava,et al. miRNA in systemic lupus erythematosus. , 2012, Clinical immunology.
[82] A. Pozzi,et al. The role of cell-extracellular matrix interactions in glomerular injury. , 2012, Experimental cell research.
[83] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[84] C. Vrabie,et al. Manifestations of systemic lupus erythematosus. , 2011, Maedica.
[85] T. Ha. The Role of MicroRNAs in Regulatory T Cells and in the Immune Response , 2011, Immune network.
[86] J. Rice,et al. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function , 2010, Proceedings of the National Academy of Sciences.
[87] N. Saini,et al. Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases , 2010, Molecular Cancer.
[88] J. Pelletier,et al. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes , 2009, BMC musculoskeletal disorders.
[89] John J Rossi,et al. SNPs in human miRNA genes affect biogenesis and function. , 2009, RNA.
[90] B. White,et al. Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.
[91] D. Leake,et al. Functional Profiling Reveals Critical Role for miRNA in Differentiation of Human Mesenchymal Stem Cells , 2009, PloS one.
[92] Kaleb M. Pauley,et al. MicroRNA in autoimmunity and autoimmune diseases. , 2009, Journal of autoimmunity.
[93] Jianping Ye,et al. A role of miR‐27 in the regulation of adipogenesis , 2009, The FEBS journal.
[94] Klaus Rajewsky,et al. MicroRNA Control in the Immune System: Basic Principles , 2009, Cell.
[95] J. Lotem,et al. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis , 2009, Proceedings of the National Academy of Sciences.
[96] J. D. de Sanctis,et al. Decreased transcription, expression and function of low-density lipoprotein receptor in leukocytes from patients with systemic lupus erythematosus , 2009, Autoimmunity.
[97] A. Nanda. Autoimmune Diseases Associated with Neurofibromatosis Type 1 , 2008, Pediatric dermatology.
[98] Shih-Chang Lin,et al. Altered FOXO1 Transcript Levels in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients , 2007, Molecular medicine.
[99] Joan Valls,et al. SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..
[100] R. Pawankar,et al. The role of matrix metalloproteinase (MMP)-2, MMP-9, and MMP-13 in bullous pemphigoid , 2004 .
[101] V. Rotter,et al. Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies. , 2001, Journal of autoimmunity.
[102] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[103] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[104] Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .